Autosomal dominant polycystic kidney disease is associated with central and nephrogenic defects in osmoregulation
- PMID: 22718190
- DOI: 10.1038/ki.2012.225
Autosomal dominant polycystic kidney disease is associated with central and nephrogenic defects in osmoregulation
Abstract
Autosomal dominant polycystic kidney disease (ADPKD) is associated with a urine-concentrating defect attributed to renal cystic changes. As PKD genes are expressed in the brain, altered central release of arginine vasopressin could also play a role. In order to help determine this we measured central and nephrogenic components of osmoregulation in 10 adults and 10 children with ADPKD, all with normal renal function, and compared them to 20 age- and gender-matched controls. Overnight water deprivation caused a lower rise in urine osmolality in the patients with ADPKD than controls, reflecting an impaired release of vasopressin and a peripheral defect in the patients. The reactivity of plasma vasopressin to water deprivation, as found in controls, was blunted in the patients with the latter showing lower urine osmolality for the same range of plasma vasopressin. The maximal urine osmolality correlated negatively with total kidney volume. Defective osmoregulation was confirmed in the children with ADPKD but was unrelated to number of renal cysts or kidney size. Thus, patients with ADPKD have an early defect in osmoregulation, with a blunted release of arginine vasopressin. This reflects expression of polycystins in hypothalamic nuclei that synthesize vasopressin, and this should be considered when evaluating treatments targeting the vasopressin pathway in ADPKD.
Comment in
-
A defect in vasopressin secretion in autosomal dominant polycystic kidney disease.Kidney Int. 2012 Nov;82(10):1051-3. doi: 10.1038/ki.2012.271. Kidney Int. 2012. PMID: 23128116
Similar articles
-
Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment.Clin J Am Soc Nephrol. 2012 Jun;7(6):906-13. doi: 10.2215/CJN.11311111. Epub 2012 Apr 19. Clin J Am Soc Nephrol. 2012. PMID: 22516290
-
Urine and plasma osmolality in patients with autosomal dominant polycystic kidney disease: reliable indicators of vasopressin activity and disease prognosis?Am J Nephrol. 2015;41(3):248-56. doi: 10.1159/000382081. Epub 2015 Apr 25. Am J Nephrol. 2015. PMID: 25926129
-
Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment.PLoS One. 2017 Jan 12;12(1):e0169263. doi: 10.1371/journal.pone.0169263. eCollection 2017. PLoS One. 2017. PMID: 28081165 Free PMC article. Clinical Trial.
-
Osmoregulation, vasopressin, and cAMP signaling in autosomal dominant polycystic kidney disease.Curr Opin Nephrol Hypertens. 2013 Jul;22(4):459-70. doi: 10.1097/MNH.0b013e3283621510. Curr Opin Nephrol Hypertens. 2013. PMID: 23736843 Review.
-
Regulation of ciliary trafficking of polycystin-2 and the pathogenesis of autosomal dominant polycystic kidney disease.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Feb;35(2):93-9. doi: 10.3969/j.issn.1672-7347.2010.02.001. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010. PMID: 20197605 Review.
Cited by
-
Urine Osmolality, Response to Tolvaptan, and Outcome in Autosomal Dominant Polycystic Kidney Disease: Results from the TEMPO 3:4 Trial.J Am Soc Nephrol. 2017 May;28(5):1592-1602. doi: 10.1681/ASN.2016040448. Epub 2016 Dec 5. J Am Soc Nephrol. 2017. PMID: 27920153 Free PMC article. Clinical Trial.
-
Apelin is altered in subjects with autosomal dominant polycystic kidney disease and preserved kidney function.Nephrol Dial Transplant. 2023 Jul 31;38(8):1907-1911. doi: 10.1093/ndt/gfad056. Nephrol Dial Transplant. 2023. PMID: 36945109 Free PMC article. No abstract available.
-
Clinical practice recommendations for kidney involvement in tuberous sclerosis complex: a consensus statement by the ERKNet Working Group for Autosomal Dominant Structural Kidney Disorders and the ERA Genes & Kidney Working Group.Nat Rev Nephrol. 2024 Jun;20(6):402-420. doi: 10.1038/s41581-024-00818-0. Epub 2024 Mar 5. Nat Rev Nephrol. 2024. PMID: 38443710 Review.
-
Novel insights into TRPV4 function in the kidney.Pflugers Arch. 2013 Feb;465(2):177-86. doi: 10.1007/s00424-012-1190-z. Epub 2012 Dec 4. Pflugers Arch. 2013. PMID: 23207579 Free PMC article. Review.
-
A Primer for Utilizing Deep Learning and Abdominal MRI Imaging Features to Monitor Autosomal Dominant Polycystic Kidney Disease Progression.Biomedicines. 2024 May 20;12(5):1133. doi: 10.3390/biomedicines12051133. Biomedicines. 2024. PMID: 38791095 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous